help button home button
AJRCCM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Published ahead of print on February 25, 2003, doi:10.1164/rccm.200204-330OC

Am. J. Respir. Crit. Care Med., Volume 167, Number 10, May 2003, 1433-1439

A more recent version of this article appeared on May 15, 2003
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
200204-330OCv1
167/10/1433    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Nunes, H.
Right arrow Articles by Simonneau, G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Nunes, H.
Right arrow Articles by Simonneau, G.

Submitted on April 23, 2002
Accepted on February 11, 2003

Prognostic factors for survival in HIV-associated pulmonary arterial hypertension

Hilario Nunes1, Marc Humbert1*, Olivier Sitbon1, Jane H Morse2, Zemin Deng3, James A Knowles3, Catherine Le Gall1, Florence Parent1, Gilles Garcia1, Philippe Herve1, Robyn J Barst2, and Gerald Simonneau1

1 Centre des Maladies Vasculaires Pulmonaires, Service de Pneumologie et Reanimation Respiratoire, Hopital Antoine Beclere, Assistance Publique -Hopitaux de Paris, Universite Paris-Sud, Clamart, France, 2 Medicine, Pediatrics and Psychiatry, Columbia University College of Physicians and Surgeons, New York, NY, USA, 3 Medicine, Pediatrics and Psychiatry, Columbia University College of Physicians and Surgeons, New York, NY, USA; The New York State Psychiatric Institute, New York, NY, USA

* To whom correspondence should be addressed. E-mail: humbert{at}ipsc.u-psud.fr.

We report a large monocentric case series of 82 patients with HIV-associated pulmonary arterial hypertension. No germline mutations of the PPH1 gene (bone morphogenetic protein receptor-II) were found in any of the 19 patients tested. Pulmonary arterial hypertension was the direct cause of death in 72% of cases. Survival rates of the overall population at 1, 2 and 3 years were 73%, 60% and 47%, respectively. Survival was significantly poorer in patients in New York Heart Association functional class III-IV at the time of diagnosis, as compared to those in functional class I-II with respective rates of 60%, 45% and 28% versus 100%, 90%, 84% at 1, 2 and 3 years (p<0.0001). Subsequently, we analyzed prognostic factors in patients in functional class III-IV. Univariate analysis indicated that CD4 lymphocyte count > 212 cells.mm-3, the use of combination antiretroviral therapy and epoprostenol infusion were related with a better survival. On multivariate analysis only CD4 lymphocyte count was an independent predictor of survival, presumably because combination antiretroviral therapy and epoprostenol infusion were strongly linked in our patient population. These results suggest that patients with severe HIV-associated pulmonary arterial hypertension should be considered for long-term epoprostenol infusion in association with combination antiretroviral therapy.
Key words: Epoprostenol, Antiretroviral therapy, Human immunodeficiency virus, Pulmonary hypertension




This article has been cited by other articles:


Home page
 Eur Respir JHome page
B. Degano, A. Yaici, J. Le Pavec, L. Savale, X. Jais, B. Camara, M. Humbert, G. Simonneau, and O. Sitbon
Long-term effects of bosentan in patients with HIV-associated pulmonary arterial hypertension
Eur. Respir. J., January 1, 2009; 33(1): 92 - 98.
[Abstract] [Full Text] [PDF]

Home page
 CirculationHome page
G. Butrous, H. A. Ghofrani, and F. Grimminger
Pulmonary Vascular Disease in the Developing World
Circulation, October 21, 2008; 118(17): 1758 - 1766.
[Full Text] [PDF]

Home page
 CirculationHome page
S. K. Grinspoon, C. Grunfeld, D. P. Kotler, J. S. Currier, J. D. Lundgren, M. P. Dube, S. E. Lipshultz, P. Y. Hsue, K. Squires, M. Schambelan, et al.
State of the Science Conference: Initiative to Decrease Cardiovascular Risk and Increase Quality of Care for Patients Living With HIV/AIDS: Executive Summary
Circulation, July 8, 2008; 118(2): 198 - 210.
[Full Text] [PDF]

Home page
 CirculationHome page
M. P. Dube, S. E. Lipshultz, C. J. Fichtenbaum, R. Greenberg, A. D. Schecter, S. D. Fisher, and for Working Group 3
Effects of HIV Infection and Antiretroviral Therapy on the Heart and Vasculature
Circulation, July 8, 2008; 118(2): e36 - e40.
[Full Text] [PDF]

Home page
 J Am Coll CardiolHome page
K. M. Chin and L. J. Rubin
Pulmonary arterial hypertension.
J. Am. Coll. Cardiol., April 22, 2008; 51(16): 1527 - 1538.
[Abstract] [Full Text] [PDF]

Home page
 Eur Respir JHome page
M. Gomberg-Maitland and H. Olschewski
Prostacyclin therapies for the treatment of pulmonary arterial hypertension
Eur. Respir. J., April 1, 2008; 31(4): 891 - 901.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Heart Circ. Physiol.Home page
S. L. Archer, M. Gomberg-Maitland, M. L. Maitland, S. Rich, J. G. N. Garcia, and E. K. Weir
Mitochondrial metabolism, redox signaling, and fusion: a mitochondria-ROS-HIF-1{alpha}-Kv1.5 O2-sensing pathway at the intersection of pulmonary hypertension and cancer
Am J Physiol Heart Circ Physiol, February 1, 2008; 294(2): H570 - H578.
[Abstract] [Full Text] [PDF]

Home page
 JAMAHome page
C. F. Barnett, P. Y. Hsue, and R. F. Machado
Pulmonary Hypertension: An Increasingly Recognized Complication of Hereditary Hemolytic Anemias and HIV Infection
JAMA, January 23, 2008; 299(3): 324 - 331.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
O. Sitbon, C. Lascoux-Combe, J.-F. Delfraissy, P. G. Yeni, F. Raffi, D. De Zuttere, V. Gressin, P. Clerson, D. Sereni, and G. Simonneau
Prevalence of HIV-related Pulmonary Arterial Hypertension in the Current Antiretroviral Therapy Era
Am. J. Respir. Crit. Care Med., January 1, 2008; 177(1): 108 - 113.
[Abstract] [Full Text] [PDF]

Home page
 Eur Respir JHome page
T. Thenappan, S. J. Shah, S. Rich, and M. Gomberg-Maitland
A USA-based registry for pulmonary arterial hypertension: 1982 2006
Eur. Respir. J., December 1, 2007; 30(6): 1103 - 1110.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Pathol.Home page
S. D. Swain, S. Han, A. Harmsen, K. Shampeny, and A. G. Harmsen
Pulmonary Hypertension Can Be a Sequela of Prior Pneumocystis Pneumonia
Am. J. Pathol., September 1, 2007; 171(3): 790 - 799.
[Abstract] [Full Text] [PDF]

Home page
 ChestHome page
H. H. Leuchte, M. El Nounou, J. C. Tuerpe, B. Hartmann, R. A. Baumgartner, M. Vogeser, O. Muehling, and J. Behr
N-terminal Pro-Brain Natriuretic Peptide and Renal Insufficiency as Predictors of Mortality in Pulmonary Hypertension
Chest, February 1, 2007; 131(2): 402 - 409.
[Abstract] [Full Text] [PDF]

Home page
 ChestHome page
K. M. Chin, R. N. Channick, and L. J. Rubin
Is Methamphetamine Use Associated With Idiopathic Pulmonary Arterial Hypertension?
Chest, December 1, 2006; 130(6): 1657 - 1663.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
J. C. Marecki, C. D. Cool, J. E. Parr, V. E. Beckey, P. A. Luciw, A. F. Tarantal, A. Carville, R. P. Shannon, A. Cota-Gomez, R. M. Tuder, et al.
HIV-1 Nef Is Associated with Complex Pulmonary Vascular Lesions in SHIV-nef-infected Macaques
Am. J. Respir. Crit. Care Med., August 15, 2006; 174(4): 437 - 445.
[Abstract] [Full Text] [PDF]

Home page
 HeartHome page
S Maiya, A A Hislop, Y Flynn, and S G Haworth
Response to bosentan in children with pulmonary hypertension
Heart, May 1, 2006; 92(5): 664 - 670.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
M. Humbert, O. Sitbon, A. Chaouat, M. Bertocchi, G. Habib, V. Gressin, A. Yaici, E. Weitzenblum, J.-F. Cordier, F. Chabot, et al.
Pulmonary Arterial Hypertension in France: Results from a National Registry
Am. J. Respir. Crit. Care Med., May 1, 2006; 173(9): 1023 - 1030.
[Abstract] [Full Text] [PDF]

Home page
 Eur Respir JHome page
D. Montani, L. Achouh, A. G. Marcelin, J-P. Viard, O. Hermine, D. Canioni, O. Sitbon, G. Simonneau, and M. Humbert
Reversibility of pulmonary arterial hypertension in HIV/HHV8-associated Castleman's disease
Eur. Respir. J., November 1, 2005; 26(5): 969 - 972.
[Abstract] [Full Text] [PDF]

Home page
 ChestHome page
E. Bossone, B. D. Bodini, A. Mazza, and L. Allegra
Pulmonary Arterial Hypertension: The Key Role of Echocardiography
Chest, May 1, 2005; 127(5): 1836 - 1843.
[Abstract] [Full Text] [PDF]

Home page
 Eur Heart JHome page
Task Force members, N. Galie, A. Torbicki, R. Barst, P. Dartevelle, S. Haworth, T. Higenbottam, H. Olschewski, A. Peacock, G. Pietra, et al.
Guidelines on diagnosis and treatment of pulmonary arterial hypertension: The Task Force on Diagnosis and Treatment of Pulmonary Arterial Hypertension of the European Society of Cardiology
Eur. Heart J., December 2, 2004; 25(24): 2243 - 2278.
[Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
O. Sitbon, V. Gressin, R. Speich, P. S. Macdonald, M. Opravil, D. A. Cooper, T. Fourme, M. Humbert, J.-F. Delfraissy, and G. Simonneau
Bosentan for the Treatment of Human Immunodeficiency Virus-associated Pulmonary Arterial Hypertension
Am. J. Respir. Crit. Care Med., December 1, 2004; 170(11): 1212 - 1217.
[Abstract] [Full Text] [PDF]

Home page
 NEJMHome page
M. Humbert, O. Sitbon, and G. Simonneau
Treatment of Pulmonary Arterial Hypertension
N. Engl. J. Med., September 30, 2004; 351(14): 1425 - 1436.
[Full Text] [PDF]

Home page
 ChestHome page
R. J. Oudiz, A. Widlitz, X. J. Beckmann, D. Camanga, J. Alfie, B. H. Brundage, and R. J. Barst
Micrococcus-Associated Central Venous Catheter Infection in Patients With Pulmonary Arterial Hypertension
Chest, July 1, 2004; 126(1): 90 - 94.
[Abstract] [Full Text] [PDF]

Home page
 ChestHome page
D. B. Badesch, S. H. Abman, G. S. Ahearn, R. J. Barst, D. C. McCrory, G. Simonneau, and V. V. McLaughlin
Medical Therapy For Pulmonary Arterial Hypertension: ACCP Evidence-Based Clinical Practice Guidelines
Chest, July 1, 2004; 126(1_suppl): 35S - 62S.
[Abstract] [Full Text] [PDF]

Home page
 J Am Coll CardiolHome page
J. H. Newman, R. C. Trembath, J. A. Morse, E. Grunig, J. E. Loyd, S. Adnot, F. Coccolo, C. Ventura, J. A. Phillips III, J. A. Knowles, et al.
Genetic basis of pulmonary arterial hypertension: Current understanding and future directions
J. Am. Coll. Cardiol., June 16, 2004; 43(12_Suppl_S): 33S - 39S.
[Abstract] [Full Text] [PDF]

Home page
 Eur Respir JHome page
H.A. Ghofrani, G. Friese, T. Discher, H. Olschewski, R.T. Schermuly, N. Weissmann, W. Seeger, F. Grimminger, and J. Lohmeyer
Inhaled iloprost is a potent acute pulmonary vasodilator in HIV-related severe pulmonary hypertension
Eur. Respir. J., February 1, 2004; 23(2): 321 - 326.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
M. J. Tobin
Tuberculosis, Lung Infections, Interstitial Lung Disease, Social Issues and Journalology in AJRCCM 2003
Am. J. Respir. Crit. Care Med., January 15, 2004; 169(2): 288 - 300.
[Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
M. J. Tobin
Chronic Obstructive Pulmonary Disease, Pollution, Pulmonary Vascular Disease, Transplantation, Pleural Disease, and Lung Cancer in AJRCCM 2003
Am. J. Respir. Crit. Care Med., January 15, 2004; 169(2): 301 - 313.
[Full Text] [PDF]

Home page
 J Am Coll CardiolHome page
R. J. Barst, M. McGoon, V. McLaughlin, V. Tapson, R. Oudiz, S. Shapiro, I. M. Robbins, R. Channick, D. Badesch, B. K. Rayburn, et al.
Beraprost therapy for pulmonary arterial hypertension
J. Am. Coll. Cardiol., June 18, 2003; 41(12): 2119 - 2125.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Proc. Am. Thorac. Soc. Am. J. Respir. Cell Mol. Biol.
Copyright © 2003 American Thoracic Society 		  ATS State of the Art Course 2008